Trametinib | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Trametinib
Health Canada Patents

PharmaCompass Sponsored Ads

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Trametinib

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

17 API Suppliers, 6 USDMF, 1 EU WC, 7 NDC API, 14 Listed Suppliers, $ API Reference Price

17 API Suppliers
6 USDMF
1 EU WC
7 NDC API
14 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

18 Drugs in Development

18 Drugs in Development

INTERMEDIATES

11 Intermediate Suppliers

11 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

24 FDF Dossiers, 8 FDA Orange Book, 5 Europe, 3 Canada, 6 Australia, 2 South Africa

24 FDF Dossiers
8 FDA Orange Book
5 Europe
3 Canada
6 Australia
2 South Africa

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 0.5MG, TABLET;ORAL - EQ 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 2MG

TABLET;ORAL - EQ 0.5MG
TABLET;ORAL - EQ 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 2MG

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 14 SPI Pharma, 2 Seqens, 3 DKSH, 4 Faran Shimi Pharmaceutical, 4 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 5 Actylis, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 15 BASF, 10 Corel Pharma Chem, 3 DFE Pharma, 1 Finar, 9 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 17 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 10 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 4 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 13 Roquette, 12 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 2 The Dow Chemical Company, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

45 Coating Systems & Additives, 38 Fillers, Diluents & Binders, 24 Controlled & Modified Release, 21 Direct Compression, 18 Thickeners and Stabilizers, 18 Disintegrants & Superdisintegrants, 16 Granulation, 16 Solubilizers, 15 Taste Masking, 13 Chewable & Orodispersible Aids, 12 Lubricants & Glidants, 11 Parenteral, 11 Co-Processed Excipients, 11 Topical, 9 Film Formers & Plasticizers, 7 Emulsifying Agents, 5 Empty Capsules, 5 API Stability Enhancers, 4 Vegetarian Capsules, 4 Coloring Agents, 4 Rheology Modifiers, 3 Surfactant & Foaming Agents

45 Coating Systems & Additives
38 Fillers, Diluents & Binders
24 Controlled & Modified Release
21 Direct Compression
18 Thickeners and Stabilizers
18 Disintegrants & Superdisintegrants
16 Granulation
16 Solubilizers
15 Taste Masking
13 Chewable & Orodispersible Aids
12 Lubricants & Glidants
11 Parenteral
11 Co-Processed Excipients
11 Topical
9 Film Formers & Plasticizers
7 Emulsifying Agents
5 Empty Capsules
5 API Stability Enhancers
4 Vegetarian Capsules
4 Coloring Agents
4 Rheology Modifiers
3 Surfactant & Foaming Agents

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 48 NEWS #PharmaBuzz

2 DATA COMPILATION #PharmaFlow
48 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 5 Finished Drug Prices, 6 Annual Reports

1 US Medicaid Prescriptions
5 Finished Drug Prices
6 Annual Reports

MARKET PLACE

3 APIs

3 APIs

PATENTS & EXCLUSIVITIES

87 US Patents, 40 US Exclusivities, 3 Health Canada Patents

87 US Patents
40 US Exclusivities
3 Health Canada Patents

$ API Ref.Price (USD/KG) : 551,952 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

3 All

01 3Gowling WLG (Canada) LLP

filter Patent Reset all filters

3 All

01 32569850

filter Product Reset all filters

3 All

01 3Trametinib

filter Dosage Reset all filters

3 All

01 3Tablet

filter Exp Date Reset all filters

3 All

01 32025-06-10

Polpharma Trametinib

Product Main Page

01

Gowling WLG (Canada) LLP

Trametinib

BioAsia

Not Confirmed

Gowling WLG (Canada) LLP

Canada

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-06-10

Date Granted : 2011-04-05

Brand Name : MEKINIST

Patent Number : 2569850

Filing Date : 2005-06-10

Strength per Unit : 0.5 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2025-06-10

Date Granted : 2011-04-05

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Gowling WLG (Canada) LLP

Trametinib

BioAsia

Not Confirmed

Gowling WLG (Canada) LLP

Canada

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-06-10

Date Granted : 2011-04-05

Brand Name : MEKINIST

Patent Number : 2569850

Filing Date : 2005-06-10

Strength per Unit : 1.0 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2025-06-10

Date Granted : 2011-04-05

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Gowling WLG (Canada) LLP

Trametinib

BioAsia

Not Confirmed

Gowling WLG (Canada) LLP

Canada

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-06-10

Date Granted : 2011-04-05

Brand Name : MEKINIST

Patent Number : 2569850

Filing Date : 2005-06-10

Strength per Unit : 2.0 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2025-06-10

Date Granted : 2011-04-05

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!